NAM
BCRX icon

Nexpoint Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Nexpoint Asset Management’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-115,000
Closed -$397K – 216
2019
Q4 		$397K Buy
+115,000
New +$397K 0.03% 206